TechCrunch

SEPTEMBER 9, 2021

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Venture investing in elder tech. Neuroglee gets $2.3

digital therapeutics 93

digital therapeutics startup health support 93

American Entrepreneurship

JUNE 20, 2024

With clearance by the FDA and reimbursement by Medicare and commercial insurance, JOGO’s funding round enables them to expand the $380B treatment market without drugs or surgery. JOGO is the first-ever digital therapeutics product to use the science of EMG biofeedback to treat neuromuscular diseases.

health 90

health digital therapeutics hospitality entrepreneurship 90

TechCrunch

NOVEMBER 3, 2021

BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.

digital therapeutics 116

digital therapeutics health ventures enablement 116

AsiaTechDaily

APRIL 30, 2022

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. With this investment, Biofourmis plans to scale up its virtual care offerings, according to the announcement.

digital therapeutics 52

digital therapeutics health accelerator board 52

TechCrunch

JULY 8, 2022

Every patient is provided a cellular enabled scale, an American Heart Association information book, exercise bands, a Bodytrace blood pressure cuff and a Garmin fitness tracker to help monitor and track their progress throughout the course.

health 92

health startup enablement ventures 92